Think.Health is a boutique venture capital firm based in Fürstenfeldbruck, Germany, investing in disruptive business models across digital healthcare, life sciences, pharmaceuticals, biotechnology, and medical technologies. The firm typically invests in early-stage ventures and growth opportunities with tickets ranging from €500k to €10m.
60% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-c (60% of deals).
Portfolio
5
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Dr. Florian Kainzinger
Managing Partner & Founder
Dr. Michael Ruoff
Partner
Nils Bottler
Venture Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Robeauté | Series B | — | Jan 2025 |
 Inflammatix, Inc. | Series C | $32M | Jan 2020 |
 sphingotec GmbH | Series C | — | Jan 2018 |
| SSphingoTec | Series C | — | — |
 PreOmics | Series A | — | — |
Top Co-Investors
Wellington Management2 shared
Brandenburg Kapital2 shared
HBM Healthcare Investments2 shared
NRW.BANK2 shared
Northpond Ventures1 shared
Scale Venture Partners1 shared
Khosla Ventures1 shared
Plural Platform1 shared
Cherry Ventures1 shared
APEX Ventures1 shared
Index Ventures1 shared
Phoenix Court Group1 shared
Kindred Ventures1 shared
High-Tech Gründerfonds1 shared
HBM Partners1 shared
Last updated: 8 September 2026